Dernières nouvelles
- Ernst, MélanieEmployéCHUL+1 418-525-4444, poste 47044Melanie.Ernst@crchudequebec.ulaval.ca
2705, boulevard Laurier
A-1602
Québec, Québec
Canada G1V 4G2 - Giannakouros, PanagiotaEmployéCHUL+1 418-525-4444, poste 40192Panagiota.Giannak@crchudequebec.ulaval.ca
2705 Boulevard Laurier
A-0121
Québec, QC
Canada G1V 4G2
Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas
Article de revueCurr Oncol, 31 (7), 2024.
A Review of the Clinical Features and Management of Systemic Congenital Mastocytosis through the Presentation of An Unusual Prenatal-Onset Case
Article de revueCurr Oncol, 30 (10), 2023.
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study
Article de revueJ Clin Oncol, 41 (10), 2023.
Germline Platelet-derived growth factor receptor beta p.R987W pathogenic variant in 2 children with brain tumors
Article de revueNeurooncol Adv, 5 (1), 2023.
Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes
Article de revueJ Med Genet, 60 (12), 2023.
Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature
Article de revueNeurooncol Adv, 4 (1), 2022.
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
Article de revueNat Med, 28 (1), 2022.
Selumetinib for symptomatic, inoperable plexiform neurofibromas in children with neurofibromatosis type 1: A national real-world case series
Article de revuePediatr Blood Cancer, 69 (8), 2022.
K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas
Article de revueNat Genet, 54 (12), 2022.
Durable Response to Trametinib in an Infant With ERC1-BRAF Infantile Fibrosarcoma-Like Tumor: A Case Report and Literature Review of BRAF-Altered Infantile Fibrosarcoma-Like Tumors
Article de revueJCO Precis Oncol, 6 , 2022.
Projets actifs
- A Phase 2 study of Trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathwa, du 2019-04-01 au 2024-09-30
- Analyse de la cohorte de neuro-oncologie pédiatrique, du 2024-04-01 au 2027-03-31
- Phase III randomized double-blind placebo-controlled trial of metformin for cognitive recovery and white matter growth in paediatric medulloblastoma patients, du 2022-06-21 au 2027-12-25
Projets terminés récemment
- Subvention pour la recherche clinique, du 2008-04-01 au 2024-03-31